Back
Day Range
$67.63
$71.68
52-Week Range
$6.45
$77.00
Volume
724,812
50D / 200D Avg
$56.05
/
$44.68
Prev Close
$70.97
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (633 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.5 | 0.2 |
| P/B | 15.5 | 2.8 |
| ROE % | -217.9 | 3.7 |
| Net Margin % | -297.1 | 3.9 |
| Rev Growth 5Y % | -14.2 | 9.7 |
| D/E | 1.7 | 0.2 |
Analyst Price Target
Hold
$136.40
+98.7%
Low: $105.00
High: $165.00
Forward EPS
-$10.10
Est. Revenue
41.23M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$10.44
-$12.84 – -$3.55
|
209.21M | 6 |
| FY2029 |
-$12.81
-$15.75 – -$4.35
|
107.89M | 6 |
| FY2028 |
-$12.96
-$19.89 – -$9.78
|
53.82M | 8 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-12 | -$2.47 | -$1.78 | +28.1% |
| 2025-11-06 | -$2.85 | -$1.85 | +35.1% |
| 2025-08-07 | -$3.13 | -$2.95 | +5.8% |
| 2025-05-08 | -$2.70 | -$3.30 | -22.2% |
| 2025-03-12 | -$1.95 | -$2.25 | -15.4% |
| 2024-11-07 | -$0.23 | -$0.18 | +21.7% |
| 2024-08-08 | -$0.21 | -$0.25 | -19.0% |
| 2024-05-09 | -$0.21 | -$0.18 | +14.3% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue declined -14.20% annually over 5 years
Negative free cash flow of -208.68M
Revenue growth is decelerating — 1Y growth trails 5Y average by 29.69%
Capital efficient — spends only 0.31% of revenue on capex
Growth
Revenue Growth (5Y)
-14.20%
Revenue (1Y)-43.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-217.94%
ROIC-41.08%
Net Margin-297.07%
Op. Margin-236.77%
Safety
Debt / Equity
1.66
Current Ratio4.97
Interest Coverage-4.99
Valuation
P/E Ratio
-8.49
Forward P/EN/A
P/B Ratio15.51
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -43.89% | Revenue Growth (3Y) | -21.71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -14.20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 55.23M | Net Income (TTM) | -164.08M |
| ROE | -217.94% | ROA | -58.51% |
| Gross Margin | 100.00% | Operating Margin | -236.77% |
| Net Margin | -297.07% | Free Cash Flow (TTM) | -208.68M |
| ROIC | -41.08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.66 | Current Ratio | 4.97 |
| Interest Coverage | -4.99 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8.49 | Forward P/E | N/A |
| P/B Ratio | 15.51 | P/S Ratio | 25.23 |
| PEG Ratio | -0.36 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 33.80 | Fwd Earnings Yield | N/A |
| FCF Yield | -14.97% | ||
| Market Cap | 1.39B | Enterprise Value | 1.53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 55.23M | 98.43M | 90.12M | 92.06M | 101.91M |
| Net Income | -164.08M | -118.96M | -276.06M | -368.20M | -523.84M |
| EPS (Diluted) | -9.73 | -8.68 | -21.79 | -29.51 | -42.90 |
| Gross Profit | 55.23M | 67.74M | 53.48M | 70.42M | 77.01M |
| Operating Income | -130.77M | -105.20M | -137.43M | -240.24M | -446.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 280.41M | 303.85M | 398.03M | 710.60M | 1.12B |
| Total Liabilities | 190.57M | 243.11M | 267.05M | 343.96M | 437.68M |
| Shareholders' Equity | 89.83M | 60.74M | 130.99M | 366.64M | 679.51M |
| Total Debt | 148.91M | 102.56M | 117.78M | 131.50M | 143.18M |
| Cash & Equivalents | 15.12M | 44.25M | 35.28M | 88.23M | 25.22M |
| Current Assets | 266.27M | 261.29M | 330.70M | 545.97M | 795.58M |
| Current Liabilities | 53.54M | 61.40M | 51.27M | 68.20M | 85.20M |